accountwidely accepted in many other countries on some of the world’s best-selling medicines. In the latest example, Bayer AG failed this week to persuade the Delhi High Court to direct India’s chief drug regulator to not give marketing approval to a...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to India Sets High Bar for Patent Protection, But Is it Too High?
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account